CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Respiratory Muscle Strength Trainersdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06091280
NCT06091280N/ACompleted

Home-Based Respiratory Muscle Strength Training Program for Individuals With Post-COVID-19 Persistent Dyspnea

University of South Florida·interventional·Posted Oct 19, 2023·Updated Apr 15, 2025

In Brief

A clinical study evaluating Respiratory Muscle Strength Trainers for Post-COVID-19 Syndrome and Dyspnea. Completed, enrolled 25 participants across 1 site.

Detailed Summary

To evaluate the extent to which a 12-week respiratory rehabilitation program consisting of inspiratory and expiratory breathing exercises compared to expiratory breathing exercises alone will help to improve shortness of breath, respiratory symptoms, breathing function, distance walked, and quality of life in those who are experiencing persistent shortness of breath after having had COVID-19. Measurements will take place at the beginning, 6 weeks, and at 12 weeks in the study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedOct 19, 2023
Enrollment StartDec 1, 2023
Primary CompletionDec 23, 2024
Study CompletionMar 14, 2025
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 2.7 years ago

Interventions

Respiratory Muscle Strength Trainersdevice

Devices provided to each participant. Resistance loading set at less than 50% of the peak inspiratory and peak expiratory flow rate.